期刊文献+

建设中医药防治血管性痴呆转化医学体系的思考 被引量:2

Construction of translational medicine system of preventing and treating vascular dementia with Chinese medicine
原文传递
导出
摘要 血管性痴呆发病率逐年增高,其病程漫长、渐进加重。目前血管性痴呆的知晓率、就诊率、治疗率低,也缺乏满意的治疗方案。应结合转化医学的理念,建立有关痴呆的古文献数据库,进行个性化的预防和治疗,建立动物研究模型,建立生物标志物数据库,积极推进社区健康促进活动,为血管性痴呆的防治提供新的思路和方法。中医药防治血管性痴呆转化医学体系建设的关键环节在于人才队伍建设和政府的支持。 The occurrence rate of vascular dementia is increasing year by year, and it has a long and ingravescence course. At present the awareness rate, rate of visiting doctor and treatment rate are lower, and there are not satisfactory therapeutic plans. Some measures should be taken including ancient literature database, personalized prevention and treatment, animal research model, biomarker database, community health improvement and new ideas and methods for preventing and curing vascular dementia. The key in construction of translational medicine system of preventing and treating vascular dementia with Chinese medicine is to build talent group and governmental support.
出处 《北京中医药大学学报(中医临床版)》 2012年第3期5-8,共4页 Journal of Beijing University of Traditional Chinese Medicine
基金 2008年中医药行业科研专项(No.200807011) 2010年中医药行业科研专项(No.201007002) 2010年度北京市社区中医药服务科技示范项目 北京市新医药学科群建设项目(No.XK100270569) 北京中医药大学创新团队发展计划(No.2011-CXTD-23) 211工程重点学科建设项目
关键词 血管性痴呆 转化医学 中医 防治 vascular dementia translational medicine Chinese medicine prevention and treatment
  • 相关文献

参考文献19

  • 1DONG M J, PENG B, LIN X T, et al. The prevalence of dementia in the People' s Republic of China: a systematic analysis of 1980-2004 studies[J]. Age Ageing, 2007, 36 (6) : 619-624.
  • 2Phagocytes and the "bench-bedside interface'[J]. N Engl J Med, 1968, 278(18): 1014-1016.
  • 3GOLD M S, DACKIS C A, POTTASH A L, et al. Cocaine update: from bench to bedside[J]. Adv Alcohol Subst Abuse, 1985, 5(1-2) : 35-60.
  • 4OSBORNE C K, CHAMNESS G C. Translational research in the San Antonio breast cancer SPORE[J]. Breast Cancer Res Treat, 1994, 32( 1 ) : 1-4.
  • 5GERAGHTY J. Adenomatous polyposis coli and translation- al medicine[J]. Lancet, 1996, 348(9025): 422.
  • 6ZERHOUN! E. Medicine: The NIH Roadmap[J]. Science, 2003, 302(5642): 63-72.
  • 7卫生部.卫生部部长陈竺出席哈佛-中国转化医学研讨会[EB/OL].[2011-12-15].http://www.gov.cn/gzclt/2011-11/09/content_1988957.htm.
  • 8王永炎,盖国忠,张志强.基于转化医学的中医药社区慢病防治策略[J].北京中医药大学学报(中医临床版),2012,19(1):1-4. 被引量:10
  • 9李平,唐启盛.转化医学理念与中医药发展新机遇[J].北京中医药大学学报(中医临床版),2012,19(1):5-9. 被引量:13
  • 10张艳霞,张允岭,薛斐然,张连成,赵建军,戴中,贾鸿雁,于洋.转化医学在中医药研究中的地位及思考[J].北京中医药大学学报(中医临床版),2012,19(1):14-16. 被引量:13

二级参考文献49

  • 1CHOI DW.Bench to bedside:the glutamate connection[J].Science,1992,258(5080):241-243.
  • 2BUTLER D.Translational research:crossing the valley of death[J].Nature,2008,453 (7197):840-842.
  • 3GERAGHTY J.Adenomatous polyposis coli and translational medicine[J].Lancet,1996,348(9025):422.
  • 4MANKOFF SP,BRANDER C,FERRONE S,et al.Lost in translation:Obstacles to translationalmedicine[J].J TranslMed,2004,2(1):14.
  • 5Phagocytes and the"bench-bedside interface"[J].N Engl J Med,1968,278 (18):1014-1016.
  • 6ADAMS JU.Building the bridge from bench to bedside[J].Nature,2008,7 (6):463-464.
  • 7MORROW GR,BELLG AJ.Behavioral science in translational reserch and cancer control[J].Cancer,1994,74(4 Suppl):1409-1417.
  • 8EDITORIAL.Human cap ital in translational research[J].Nature Reviews Drug Discovery,2008,7(6):461.
  • 9WADMAN M.Harvard turns to matchmaking to speed translational research[J].Nature Medicine,2008,14(7):697.
  • 10WOOLF SH.The meaning of translational research and why it matters[J].Jana,2008,299 (2):211-213.

共引文献164

同被引文献25

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部